نتایج جستجو برای: 7 receptor alpha multiple sclerosis

تعداد نتایج: 2036610  

The purpose of this scientometric study is to analyze the multiple sclerosis research in Science Citation Index-Expanded from 1992 to 2019 in order to determine the top features, trends, and topics. Articles related to multiple sclerosis in the section of title, abstract, keywords, and KeyWords Plus were retrieved from the Science Citation Index-Expanded and analyzed based on various indicators...

Journal: :مجله علوم اعصاب شفای خاتم 0
petra hundehege university hospital münster, neurology clinic and institute of translational neurology, icb mendelstraße 7, 48149 münster, germany

multiple sclerosis (ms) is a chronic inflammatory disease of the central nervous system characterized by widespread inflammation, focal demyelination and a variable degree of axonal and neuronal loss. ionic conductances regulate t cell activation as well as neuronal function and thus have been found to play a crucial role in ms pathogenesis. since present therapeutical approaches are only parti...

Journal: :مجله علوم اعصاب شفای خاتم 0
a delank universitätsklinikum münster, institut für translationale neurologie, münster, germany m cerina universitätsklinikum münster, institut für translationale neurologie, münster, germany v narayanan universitätsklinikum münster, institut für translationale neurologie, münster, germany a herrmann universitätsklinikum münster, institut für translationale neurologie, münster, germany t ruck universitätsklinikum münster, institut für translationale neurologie, münster, germany s.g meuth universitätsklinikum münster, institut für translationale neurologie, münster, germany

multiple sclerosis is an autoimmune cns-disease characterized by inflammatory neurodegenerative events occurring with de- and remyelination. recent evidence show that demyelinated neurons are less excitable than myelinated ones while at early stages of remyelination these neurons seem to be hyperexcitable. the latter is a transitory condition that, very likely, leads to impaired neuronal networ...

Journal: :iranian journal of neurology 0
seyed mohammad baghbanian ‎department of neurology, school of medicine and booalisina hospital, mazandaran university of ‎medical sciences, sari, iran

--

Ahsan , Behrooz, Fayazi , Bayan, Parnow , Abdolhossein,

Introduction: Multiple Sclerosis Multiple Sclerosis is a chronic and autoimmune disease. Muscle weakness and fatigue leads to decreased functional capacities and diminished quality of life in Multiple Sclerosis patients Objective: The purpose of this study was to determine the effect of aerobic exercises on fatigue and quality of life in women with Multiple Sclerosis Methods: Fifteen wome...

Journal: :Brain : a journal of neurology 2002
Christine Stadelmann Martin Kerschensteiner Thomas Misgeld Wolfgang Brück Reinhard Hohlfeld Hans Lassmann

Recent immunohistological and imaging studies emphasize the crucial role of axonal injury in determining the extent of permanent neurological deficits in patients with multiple sclerosis. We have recently shown that human immune cells are capable of producing the neurotrophin brain-derived neurotrophic factor (BDNF), which can prevent axonal and neuronal damage after various pathological insult...

2007
Wanis H Ibrahim Mohammed Hammoudah Naveed Akhtar Hassan Al-Hail Dirk Deleu

There are few case reports documenting a new onset of demyelinating processes in patients receiving anti-tumour necrosis factor alpha therapy (anti-TNF alpha) for chronic inflammatory arthropathies. Whether anti-TNF alpha therapy induces new onset demyelination or just exacerbates pre-existing latent multiple sclerosis is not fully understood. We are reporting a 51-year-old woman without a prio...

ایلالی, احترام السادات, ترقی, زهره, خوش نما, ابراهیم, زروانی, اشرف, عابدینی, محمود, قانعی, نفیسه, محمد پور, رضا علی, مختار پور, راضیه,

  Introduction and Aim: MS is one of the progressive and chronic demyelinative disorders involving active members of society. The study of quality of life in these patients could decrease relieve some disabilities and promotes residual abilities to maximal levels. Regarding relatively high prevalence of MS in Mazandaran province, this study was designed to measure the quality of life in Multipl...

Journal: :Journal of Maine Medical Center 2021

Introduction: Natalizumab is an integrin receptor antagonist that has been approved by the Food and Drug Administration to treat multiple sclerosis Crohn’s disease. The drug linked increased risk of melanoma. This brief report highlights innovative clinical approach for monitoring skin patients prescribed natalizumab.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید